鲁抗医药 (600789.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.1x

Market Cap

CNY 7.52B

MomentumView details →

1D Return

−1.91%

YTD Return

−16.15%

RSI (14)

52.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.1x

Market Cap

CNY 7.52B

RSI (14)

52.4

MomentumView details →

1D Return

−1.91%

YTD Return

−16.15%

ProfitabilityView details →

Gross Margin

22.26%

Net Margin

1.52%

EBITDA Margin

10.69%

ROE (TTM)

1.68%

ROA (TTM)

0.88%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

−6.54%

EPS YoY

−80.13%

FCF YoY

+1900.12%

Revenue CAGR 3Y

+0.85%

EPS CAGR 3Y

−9.14%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.40x

Current Ratio

1.53x

Quick Ratio

1.14x

Div Yield

0.66%

Div Rate

CNY 0.05

Div Growth 1Y

−55.36%

Financials snapshotView financials →

Revenue (TTM)

5.71B

Net Income (TTM)

86.96M

Op. CF (TTM)

835.43M

Latest newsMore news →

Lukang Pharmaceutical's controlling subsidiary Shandong Lukang Pharmaceutical Group Saite Co., Ltd. received approval from the National Medical Products Administration to become the marketing authorization holder of Crisaborole Ointment, transferring the holder from Zhejiang Saimei Pharmaceutical Co., Ltd. to Saite.17d ago

Lukang Pharmaceutical received drug registration certificates from the National Medical Products Administration for dapagliflozin and metformin extended-release tablets (I) and (III), a combination product indicated for adults with type 2 diabetes.29d ago

Similar companies

汇宇制药-W688553.SH 上海谊众688091.SH Sihuan Pharmaceutical Holdings Group Ltd.00460.HK 阳光诺和688621.SH CanSino Biologics Inc.06185.HK 太极集团600129.SH Find similar companies →

Latest newsMore news →

Lukang Pharmaceutical's controlling subsidiary Shandong Lukang Pharmaceutical Group Saite Co., Ltd. received approval from the National Medical Products Administration to become the marketing authorization holder of Crisaborole Ointment, transferring the holder from Zhejiang Saimei Pharmaceutical Co., Ltd. to Saite.17d ago Lukang Pharmaceutical received drug registration certificates from the National Medical Products Administration for dapagliflozin and metformin extended-release tablets (I) and (III), a combination product indicated for adults with type 2 diabetes.29d ago